Precise Gene Editing in Early Human Embryos Reignites the 'Designer Baby' Debate

The technology, still far from clinical use, could one day prevent devastating diseases. But critics warn that even these early results may also fuel interest in commercial embryo editing, despite unresolved ethical and safety concerns.